Step therapy for oral methotrexate products (Jylamvo, Xatmep)
Customize your policy alerts
Sign up for simplyhealthcare Policy MTX alerts
Get alerted when Policy MTX changes without checking for updates manually.
Monitor payer policy activity
This policy governs step therapy requirements for specified oral methotrexate products (Jylamvo and Xatmep) for Simply Healthcare Plans members. It defines required prior trial of an initial step drug before coverage of the branded/step-2 products.
No material clinical or coverage changes in this revision.
Coverage Criteria
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.